CPT Code 99409: SBIRT Screening, >30 Min
CPT code 99409 for extended alcohol and substance abuse screening and brief intervention (SBIRT), over 30 minutes. Behavioral health billing.
Payer-specific values for this code, including authenticated Aetna rates, are in the 2026 Aetna coding guide.
- CPT Codes
- 99409
CPT Code 99409: SBIRT Screening, >30 Min
CPT code 99409 for extended alcohol and substance abuse screening and brief intervention (SBIRT), over 30 minutes. Behavioral health billing.
Quick Reference
- Code
- 99409
- Code System
- CPT
- Category
- CPT Codes
- Published
- Mar 4, 2026
- Reading Time
- 9 min
CPT® is a registered trademark of the American Medical Association. All CPT code descriptions on this page are paraphrased in original wording; consult the current CPT® codebook published by the AMA for authoritative descriptors.
Understanding CPT Code 99409: SBIRT Screening and Brief Intervention, Greater Than 30 Minutes
CPT code 99409 covers extended alcohol and/or substance abuse structured screening and brief intervention ( SBIRT ) services lasting greater than 30 minutes. This code addresses clinical situations where the standard 15-to-30-minute SBIRT encounter captured by CPT 99408 is insufficient to complete the necessary screening, feedback, and intervention activities. In behavioral health treatment, where patients frequently present with complex, multi- substance use disorder patterns and significant co-occurring conditions, extended SBIRT services are a regular clinical necessity.
The additional time captured by 99409 allows providers to conduct more thorough assessments, deliver more intensive motivational interventions, and develop more comprehensive referral and action plans. For behavioral health organizations, proper use of 99409 ensures that complex SBIRT encounters are fully compensated.
Definition and Purpose
CPT code 99409 describes alcohol and/or substance (other than tobacco) abuse structured screening and brief intervention services, greater than 30 minutes. It shares the same core service definition as 99408 but applies when the clinical encounter requires substantially more time.
Extended screening scope. The greater-than-30-minute threshold for 99409 reflects clinical encounters where the screening component is more extensive. This may involve administering multiple validated screening instruments to assess different substances, conducting a more detailed substance use history to contextualize screening results, or assessing complex patterns of polysubstance use that require careful differentiation.
Intensive brief intervention. The brief intervention component of an extended SBIRT encounter typically involves more in-depth motivational interviewing, exploration of complex ambivalence about change across multiple substances, detailed feedback about health risks and the interaction of multiple substance use patterns, development of comprehensive harm reduction or abstinence strategies, and extended goal setting for patients facing multiple simultaneous change targets.
Comprehensive referral planning. When screening indicates a need for referral to specialized treatment, the extended time in 99409 allows for more thorough discussion of treatment options, identification and resolution of barriers to accessing care, coordination with treatment providers, and development of a transition plan.
No upper time limit defined. Unlike the 15-to-30-minute window for 99408, CPT 99409 has no defined upper time limit. However, all time counted must be directly related to the SBIRT service and must be documented with medical necessity justification.
When to Use in Behavioral Health
Extended SBIRT services are particularly common in behavioral health settings where patients present with complex substance use profiles.
Polysubstance use assessments. Patients who use multiple substances, including combinations of alcohol, opioids, stimulants, benzodiazepines, and cannabis, require screening for each substance category, assessment of interactions between substances, and development of intervention strategies that address the full spectrum of their use. These encounters routinely exceed 30 minutes.
Complex co-occurring disorder presentations. When substance use screening is conducted alongside assessment of severe mental health conditions such as psychotic disorders, bipolar disorder, or complex PTSD, the interplay between psychiatric symptoms and substance use patterns requires extended exploration. Understanding how each condition influences the other is essential for effective intervention planning.
Patients with high resistance or ambivalence. Some patients present with significant resistance to discussing their substance use or profound ambivalence about change. Extended motivational interviewing sessions that carefully build rapport, explore discrepancy, and support self-efficacy take time. When the SBIRT encounter must navigate substantial resistance, 99409 captures the additional clinical effort.
Comprehensive intake screenings. During initial assessments at substance use disorder treatment programs, the SBIRT process may be integrated into a comprehensive intake that includes detailed substance use chronology, assessment of withdrawal risk, evaluation of prior treatment history and outcomes, and identification of social determinants that affect treatment access and success.
Adolescent and young adult assessments. SBIRT with younger patients may require additional time for age-appropriate engagement strategies, screening with instruments validated for younger populations, exploration of peer and family influences on substance use, and discussion of developmental impacts of substance use.
Court-ordered or mandated assessments. Patients referred through the criminal justice system or child protective services may require extended SBIRT encounters due to the need for more thorough documentation, discussion of legal implications, and coordination with referring agencies.
Documentation Requirements
Extended SBIRT encounters documented under 99409 require particularly thorough clinical notes given the longer duration and higher reimbursement.
Screening instrument documentation. Record each validated screening instrument administered, including the specific instrument name, version, and scoring methodology. Document the patient’s individual item responses or total scores, the clinical interpretation of each screening result, and how multiple screening results were synthesized to form a comprehensive assessment of the patient’s substance use.
Risk stratification. Clearly document the patient’s risk level based on screening results. For patients with polysubstance use, document the risk level for each substance category and the overall clinical picture.
Detailed intervention notes. For extended brief interventions, document the motivational interviewing strategies used, the patient’s statements about their substance use (using the patient’s own words when possible), identification of discrepancy between the patient’s goals and their current substance use patterns, the patient’s expressed willingness and confidence to change, specific barriers to change identified and addressed, and any harm reduction strategies discussed and agreed upon.
Time documentation. Record the total time spent on SBIRT services. The documentation must clearly establish that the encounter exceeded 30 minutes. For example: “SBIRT screening and brief intervention provided face-to-face for 48 minutes, including administration of AUDIT (12 minutes), DAST-10 (8 minutes), feedback and motivational interviewing (22 minutes), and referral planning (6 minutes).”
Referral documentation. If referral to specialized treatment is part of the SBIRT encounter, document the specific referral recommendations, the patient’s response to referral options, any barriers to referral identified and addressed, contact information for referral resources provided, and follow-up plans for monitoring referral completion.
Medical necessity justification. Explain why the SBIRT encounter required more than 30 minutes. Reference the specific clinical factors that necessitated extended time, such as polysubstance use, complex psychiatric comorbidity, or significant patient ambivalence.
Billing and Reimbursement
As of March 2026, CPT 99409 reimburses at a higher rate than 99408, reflecting the additional clinical time and complexity involved.
Medicare billing considerations. Medicare may require HCPCS codes G0396 and G0397 instead of CPT 99408 and 99409 for SBIRT services. G0396 covers 15-30 minutes and G0397 covers greater than 30 minutes, mirroring the CPT code structure. Verify with your Medicare Administrative Contractor which code set to use. Some MACs accept both code sets, while others require exclusively HCPCS codes for Medicare SBIRT claims.
Diagnosis coding. For screening encounters, use ICD-10 code Z13.39 or Z13.89. When the screening identifies a substance use disorder, report the appropriate F10-F19 code based on the substance and severity level. For polysubstance presentations, report all applicable substance use diagnosis codes.
Commercial payer coverage. Commercial payer coverage for extended SBIRT services varies. Some payers cover 99409 under preventive benefits, while others require a substance use diagnosis to support the claim. Verify coverage terms, frequency limits, and eligible provider types with each payer.
Same-day billing. CPT 99409 can be reported on the same date as E&M services, psychotherapy, or other behavioral health codes. Append modifier 25 to the E&M code when both services are reported. Ensure documentation clearly separates the SBIRT service from other services with non-overlapping time records.
Frequency considerations. While SBIRT is typically performed at intake or annually, clinical circumstances may warrant more frequent screening for patients in active treatment, those with changing substance use patterns, or those transitioning between levels of care. Document the clinical rationale for any screening performed more frequently than annually.
Common Modifiers
Modifier 25 is applied to the accompanying E&M code when both an E&M service and 99409 are reported on the same date.
Modifier 33 designates the service as preventive care. Use this modifier when the payer requires it for correct claims processing under preventive benefits.
Modifier 95 indicates synchronous telemedicine delivery. Extended SBIRT services may be provided via telehealth when validated screening can be administered effectively in a virtual setting. Some instruments may need adaptation for telehealth administration.
Modifier 52 should not be used with 99409. If SBIRT services last 30 minutes or less, report 99408 instead.
Modifier 59 or XE may be required to distinguish 99409 from other behavioral health services provided on the same date if the payer’s claim editing system bundles them.
Compliance Considerations
Extended SBIRT encounters carry higher compliance risk due to their longer duration and higher reimbursement. Behavioral health organizations should maintain rigorous compliance practices.
Validated instrument requirement. Every SBIRT encounter must use one or more validated screening instruments. Informal conversations about substance use, even when thorough, do not meet the structured screening requirement. Maintain a list of approved screening instruments and ensure all clinical staff are trained on their proper administration.
Time documentation rigor. For encounters exceeding 30 minutes, time documentation must be specific and supported by clinical content that justifies the extended duration. Notes that document 31 minutes of SBIRT without detailed content description may be viewed as suspect. Include enough clinical detail to demonstrate what was accomplished during the reported time.
Distinction from diagnostic assessment. SBIRT is a screening and brief intervention service, not a comprehensive diagnostic assessment. While there is clinical overlap, particularly for patients who screen positive for substance use disorders, the SBIRT encounter should be documented as a screening and intervention service rather than a full diagnostic evaluation. If a comprehensive diagnostic assessment is warranted, it should be billed under the appropriate diagnostic code.
Avoid duplication with other screening services. Ensure that SBIRT services do not duplicate other substance use screening or assessment services provided on the same date. Each service must represent a distinct clinical activity with separate time and documentation.
Staff credentialing. Verify that all providers delivering SBIRT services under 99409 meet payer requirements for eligible provider types. Maintain current credentialing records and verify that supervision requirements are met for non-independently licensed staff.
Regular compliance audits. Include SBIRT claims in your regular billing compliance audit cycle. Review a sample of 99409 claims quarterly to verify that validated instruments were used, time is accurately documented, clinical content supports the reported duration, and referral documentation is complete when applicable.
Related Billing Codes
- 99406
- 99407
- 99408
- 99484
- 99492
- 99493
Common questions
Official sources
No publisher link is recorded for this topic yet. Confirm the requirement with the governing payer, state agency or accreditor before relying on it — see the primary source directory.